2010 annual financial data
GT Biopharma 2010 Operating margin
Direct answer
Operating margin was -22,700%.
Operating income was -2,497,000 USD and net income was -2,995,000 USD.
Operating cash flow was -1,535,000 USD.
Get free GT Biopharma email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 11,000 USD
- Operating income
- -2,497,000 USD
- Net income
- -2,995,000 USD
- Operating cash flow
- -1,535,000 USD